Search

everythinglearnresearchcommunity

for

Search:↓

PRP-based treatments can increase hair density, but results vary among individuals.

Platelet-rich plasma may improve hair density in androgenetic alopecia patients.

Stem cells are key for hair follicle recovery.

The new device improves hair transplant results by enhancing follicle viability and allowing more grafts in one day.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

Disease-specific tools better assess quality of life in alopecia areata patients.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

AA-PRP injections significantly promote hair growth but need better study design for clear efficacy.

Scalp skin grafts effectively cover lower limb defects with high success and minimal complications.

Micrografting may improve healing and hair growth, but more research is needed.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Hair follicles and urine cell pellets are promising for transcriptome studies due to consistent quality and useful expression profiles.

The document concludes that objective methods are important for diagnosing different types of alopecia and monitoring treatment, and standardizing these techniques is necessary.

PRP treatment may help with alopecia areata, especially in newer cases.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

Tissue-engineered skin can support hair growth after grafting, especially with mouse-derived dermis.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

The Aligned membranes improved wound healing and hair growth with a better immune response in mice.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Both fat-derived stem cells and platelet-rich plasma are effective and safe for hair loss, but stem cells give better results with more side effects.

Repeated PRP injections for hair loss can cause increased pain sensitivity.

Intradermal testing can better detect corticosteroid allergies than patch testing.

CAR is a useful marker for assessing alopecia areata severity.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.